The Status of Oral Drugs for Chronic Central Serous Chorioretinopathy

The document reviewed the current status of oral drug treatments for chronic central serous chorioretinopathy (CSC). It discussed various medications, their mechanisms, and effectiveness in managing CSC. The review highlighted that while some oral drugs showed promise in reducing subretinal fluid and improving visual acuity, the overall efficacy and safety profiles varied. The need for further large-scale, randomized controlled trials to establish standardized treatment protocols was emphasized.